What’s next for the life sciences industry? Four trends to watch in 2024
2023 was an eventful year for the life sciences industry, with the Inflation Reduction Act (IRA) and game-changing technology like ChatGPT dominating the headlines. Will biopharma’s constrained budgets, reorganizations, and reductions in force continue in 2024, or will there be a healthy rebound from these prunings? Only time will tell. There are positive developments on […]
Worries and Hopes for Healthcare Delivery in 2024
Industry experts from Norstella – a family of brands that includes, Citeline, the Dedham Group, Evaluate, MMIT, and Panalgo, and whose data and technologies support decision making from R&D through to market access – share their worries and hopes going into 2024. Read the Full Article
Prepping for the Inflation Reduction Act: Why Manufacturers Need a Plan for Rapid RWE Generation
Since the passing of the Inflation Reduction Act (IRA) in August 2022, the healthcare industry has been bracing for the impact of several key provisions. Three of these policies—price negotiations, inflation-adjusted rebates, and the out-of-pocket spending cap—will be at least partially in place by the close of 2023. As manufacturers prepare for the effects of […]
The Pressure To Publish Rapidly: The Risks Vs. Rewards Of Fast-Tracked COVID-19 Studies
In this article with Health IT Outcomes, Joseph Menzin discusses fast-tracked COVID-19 studies, noting that with the fear surrounding the pandemic and the pressure to both understand the disease and find a cure, it’s not surprising the publication of scientific papers is being rushed. However, there are limitations of these fast-tracked studies that we must consider […]
Economic Burden of Treatment Resistant Depression on the US Health Care System
Authors: M Sussman, A O’Sullivan, A Shah, M Olfson, J Menzin Published: Journal of Managed Care and Specialty Pharmacy Click here to view the article.